Allogene gains on FDA designations to cell therapy (ALLO:NASDAQ)
· seekingalpha.com
Allogene Therapeutics (ALLO) stock jumps as the FDA grants RMAT & Fast Track designation to the company's CAR-T cell therapy cema-cel. Read more here.
Shares of Allogene Therapeutics (ALLO) rose on Wednesday after the U.S. Food and Drug Administration awarded the Regenerative Medicine Advanced Therapy (RMAT) a...